{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:50:23Z","timestamp":1789671023147,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005349","name":"American Association of Colleges of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.numecd.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T08:28:51Z","timestamp":1621326531000},"page":"2507-2511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of sodium-glucose cotransporter-2 inhibitors on appetite markers in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"31","author":[{"given":"Sara M.","family":"McMillin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-859X","authenticated-orcid":false,"given":"Mimi L.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-0644","authenticated-orcid":false,"given":"Christina H.","family":"Sherrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2021.05.005_bib1","series-title":"National diabetes statistics report","year":"2020"},{"issue":"7","key":"10.1016\/j.numecd.2021.05.005_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.numecd.2021.05.005_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2017.04.011","article-title":"Sodium-glucose co-transporters and their inhibition: clinical physiology","volume":"26","author":"Ferrannini","year":"2017","journal-title":"Cell Metabol"},{"issue":"9","key":"10.1016\/j.numecd.2021.05.005_bib4","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc15-0355","article-title":"Energy balance after sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Ferrannini","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.05.005_bib5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00421-011-2154-2","article-title":"Ghrelin and PYY levels in adolescents with severe obesity: effects of weight loss induced by long-term exercise training and modified food habits","volume":"112","author":"Gueugnon","year":"2012","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.numecd.2021.05.005_bib6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ijo.2010.48","article-title":"Effect of weight loss by a low-fat diet and a low-carbohydrate diet on peptide YY levels","volume":"34","author":"Essah","year":"2010","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.numecd.2021.05.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10284150400027107","article-title":"Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity","volume":"8","author":"Popovic","year":"2005","journal-title":"Nutr Neurosci"},{"issue":"11","key":"10.1016\/j.numecd.2021.05.005_bib8","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/oby.21653","article-title":"How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake","volume":"24","author":"Polidori","year":"2016","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.numecd.2021.05.005_bib9","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/oby.2012.59","article-title":"Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats","volume":"20","author":"Devenny","year":"2012","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.numecd.2021.05.005_bib10","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1038\/s41598-018-27181-y","article-title":"Metabolomic and microarray analyses of adipose tissue of dapagliflozin-treated mice, and effects of 3-hydroxybutyrate on induction of adiponectin in adipocytes","volume":"8","author":"Nishitani","year":"2018","journal-title":"Sci Rep"},{"issue":"Supplement 1","key":"10.1016\/j.numecd.2021.05.005_bib11","article-title":"Changes in energy balance during dapagliflozin therapy in type 2 diabetes-the Energize study","volume":"67","author":"Rajeev","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2021.05.005_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.diabres.2017.11.016","article-title":"Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment","volume":"135","author":"Horie","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.numecd.2021.05.005_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0007114500001719","article-title":"The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings","volume":"84","author":"Stubbs","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1016\/j.numecd.2021.05.005_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41581-020-00350-x","article-title":"Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation","volume":"17","author":"Marton","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.numecd.2021.05.005_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.05.005_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2018.02.002","article-title":"Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes","volume":"85","author":"Garvey","year":"2018","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.numecd.2021.05.005_bib17","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/jcem.87.6.8738","article-title":"Food fails to suppress ghrelin levels in obese humans","volume":"87","author":"English","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532100226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532100226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:20:26Z","timestamp":1760545226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532100226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S093947532100226X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.05.005","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of sodium-glucose cotransporter-2 inhibitors on appetite markers in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}